Kunihiko Kimura

Title: Kunihiko Kimura: Innovator in Pharmaceutical Chemistry

Introduction

Kunihiko Kimura is a notable inventor based in Fukushima, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of prodrugs for treating circulatory diseases.

Latest Patents

One of his key patents is for a proline ester and preparation containing the same for percutaneous administration. This proline ester is represented by a specific formula, where R denotes a hydroxy-lower alkyl group, a lower alkoxy-lower alkyl group, or a lower alkoxy-lower alkoxy-lower alkyl group, or a pharmaceutically acceptable salt thereof. The invention is particularly useful as a prodrug of enalaprilat, a medication effective in preventing or treating various circulatory diseases, including hypertension and cardiac conditions. The formulation of this drug is ideally suited for percutaneous delivery, especially in patch form, enhancing its medicinal efficacy.

Career Highlights

Kunihiko Kimura is associated with Toa Eiyo Ltd., where he continues to innovate in the pharmaceutical sector. His work has been instrumental in advancing drug formulations that improve patient outcomes.

Collaborations

He has collaborated with notable colleagues, including Miho Komine and Kunihiro Minami, contributing to a dynamic research environment that fosters innovation.

Conclusion

Kunihiko Kimura's contributions to pharmaceutical chemistry, particularly through his patent on proline esters, highlight his role as a significant inventor in the field. His work continues to impact the treatment of circulatory diseases, showcasing the importance of innovation in medicine.